Evidence map›Paper›PMID 30143753›Full record

ArticleNature immunology2018

Publisher Correction: Gene regulation: c-Maf in CD4

W Nicholas Haining, Sarah A Weiss

Open access · bronzeAbstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Nature immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 91% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

W Nicholas HainingDepartment of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. wnhaining@gmail.com.ORCID http://orcid.org/0000-0001-7871-3762
Sarah A WeissDepartment of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Broad Institute · USHarvard University · US

Funding

Cancer Immunology Training GrantT32CA207021 · NCI · DANA-FARBER CANCER INST · PI WUCHERPFENNIG, KAI W · 2016 to 2020
$2.4M
NCI NIH HHS T32 CA207021
6 · The paper itself

Abstract

In the version of this article initially published, two sentences in the seventh paragraph (which begins "To delve more deeply") had incorrect text: the seventh sentence (which begins "Moreover, the decreased") stated "treatment of the mice with a blocking antibody"; the next sentence (which begins "These data") stated "that in turn has important consequences...". The correct text is as follows: "treatment of the cells with a blocking antibody" (in the seventh sentence); and "in turn might have important consequences" (in the next sentence). Also, Fig. 1 included two errors: at the top right, the arrow from c-Maf to NFAT2 should be a dashed line with a 'T' end at the top (not an arrowhead), and the 'T' from NFAT2 to IL-2 below should be a downward arrow. The error has been corrected in the HTML and PDF version of the article.

Identifiers

PMID30143753
OpenAlexW2888019711

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.